Orthofix Medical, Inc. (OFIX)

13.37 -0.16 (-1.18%) USD  |  NASDAQ  |  Mar 02, 16:00
13.38 +0.01 (+0.07%) Pre-Market: 20:00
More

Orthofix Medical Research and Development Expense (Annual) : 65.85M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for OFIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Repligen Corp. 51.31M
InfuSystem Holdings, Inc. --
Tandem Diabetes Care, Inc. 174.84M
Abbott Laboratories 2.889B
Plus Therapeutics, Inc. 10.58M